TI
CVS icon

tru Independence’s CVS Health CVS Stock Holding History

tru Independence’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,479
Closed -$5.43M – 110
2025
Q4 		$5.43M Sell
68,479
-1,958
-3% -$154K 1.37% 26
2025
Q3 		$5.31M Sell
70,437
-195
-0.3% -$13.4K 1.38% 26
2025
Q2 		$4.87M Sell
70,632
-110
-0.2% -$7.21K 1.41% 31
2025
Q1 		$4.79M Buy
70,742
+2,437
+4% +$146K 1.49% 26
2024
Q4 		$3.07M Sell
68,305
-5,542
-8% -$311K 0.96% 44
2024
Q3 		$4.64M Sell
73,847
-40
-0.1% -$2.33K 1.36% 36
2024
Q2 		$4.36M Buy
73,887
+1,103
+2% +$69K 1.32% 39
2024
Q1 		$5.81M Sell
72,784
-690
-0.9% -$52.7K 1.71% 21
2023
Q4 		$5.8M Sell
73,474
-393
-0.5% -$28K 1.76% 17
2023
Q3 		$5.16M Buy
73,867
+2,242
+3% +$159K 1.78% 21
2023
Q2 		$4.95M Buy
71,625
+4,236
+6% +$301K 1.63% 26
2023
Q1 		$5.01M Buy
67,389
+946
+1% +$79.3K 1.61% 29
2022
Q4 		$6.19M Sell
66,443
-7,431
-10% -$717K 2.01% 13
2022
Q3 		$7.04M Sell
73,874
-2,798
-4% -$277K 2.49% 1
2022
Q2 		$7.1M Sell
76,672
-5,113
-6% -$499K 2.28% 1
2022
Q1 		$8.28M Sell
81,785
-913
-1% -$95.9K 2.24% 3
2021
Q4 		$8.53M Sell
82,698
-2,236
-3% -$207K 2.33% 2
2021
Q3 		$7.21M Sell
84,934
-2,378
-3% -$199K 2.02% 3
2021
Q2 		$7.29M Sell
87,312
-917
-1% -$75.1K 2.15% 6
2021
Q1 		$6.64M Sell
88,229
-372
-0.4% -$27.1K 1.26% 17
2020
Q4 		$6.05K Sell
88,601
-1,604
-2% -$104K 0.01% 280
2020
Q3 		$5.27M Sell
90,205
-32,507
-26% -$2.02M 1.49% 22
2020
Q2 		$7.97K Sell
122,712
-146
-0.1% -$9.19K 1.15% 11
2020
Q1 		$7.29K Sell
122,858
-4,105
-3% -$274K 1.19% 13
2019
Q4 		$8.92M Buy
+126,963
New +$8.91M 1.28% 19

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

tru Independence's CVS Position: Q1 2026 in Review

tru Independence sold out of CVS Health (CVS) in Q1 2026, closing a stake of 68,479 shares — an estimated $5.43M sold.

tru Independence first reported a position in CVS in Q4 2019 and held it in 25 quarters. The position peaked at $8.92M in Q4 2019. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • tru Independence reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • tru Independence sold 68,479 CVS Health shares in Q1 2026, an estimated $5.43M.
  • tru Independence first reported a position in CVS Health in Q4 2019 and held it in 25 quarters.
  • tru Independence's CVS Health position peaked at $8.92M in Q4 2019.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on tru Independence's 13F filing for Q1 2026, filed 22 Apr 2026.